RadioMedix $2.8 Million Grant from Texas Emerging Technology Fund to Result in New Products that Benefit Carcinoid and Neuroendocrine Cancer Patients
Two innovative products that will enable users to generate and label PET radiotracers on-site at a significantly reduced cost will be developed by RadioMedix, Inc. with a $2.8 million grant from the Texas Emerging Technology Fund. According to Ebrahim…
READ MORECarcinoid Cancer Foundation Symposium Features Leading NET Cancer Specialists & a Patient Panel
What are the most state-of-the-art treatments for carcinoid and NET cancer patients today? Join us on May 1st when the Carcinoid Cancer Foundation presents its 14th Annual Symposium, “Neuroendocrine Tumor Management: The Era of Personalized…
READ MORENeuroendocrine Tumors Featured on Healthy Body, Healthy Mind Television Series
For a comprehensive overview of neuroendocrine tumors, watch this fascinating video on the Healthy Body, Healthy Mind television series. Every episode on the health and wellness TV series focuses on the stories of real people; people who are working…
READ MOREWebMD Articles Raise Awareness about Carcinoid Cancer
Understanding carcinoid tumors, carcinoid syndrome, and treatments for carcinoid when surgery is not an option are the focus of three feature articles by Ellen Greenlaw on WebMD.com this month. For these articles, Ms. Greenlaw sought the expertise…
READ MORECarcinoid Cancer Foundation Thanks Steve Jobs for Bringing about Greater Awareness of Neuroendocrine Cancers
Since the announcement was made earlier this month that Apple’s CEO Steve Jobs would be taking a medical leave of absence there has been significant media coverage about pancreatic neuroendocrine tumors, NET cancer, and carcinoid. Although…
READ MORECarcinoid and NET Patients: Honor Your Oncology Nurse
If you are a carcinoid or neuroendocrine cancer patient or caregiver for whom an oncology nurse has made an enormous difference, now you can nominate that nurse for CURE’s 2011 Extraordinary Healer Award for Oncology Nursing. This is a unique opportunity…
READ MORE17 iPhone, Android, and BlackBerry Apps for Carcinoid Patients and Physicians
There are a growing number of invaluable apps for carcinoid cancer patients and physicians who own iPhones, Droids, or a BlackBerry. Whether you are looking for a way to store personal medical information, find emergency phone numbers in more than 130…
READ MORECarcinoid Cancer Foundation Asks You to Help Support Rare Disease Day: Write Your Reps Campaign
Carcinoid patients, physicians, family, friends and colleagues can help support Rare Disease Day 2011 by participating in NORD’s Write Your Reps Campaign. NORD (National Organization for Rare Diseases) and its advocacy partners have worked with…
READ MOREFortune Reports That Steve Jobs Sought Neuroendocrine Cancer Treatment in Switzerland
Fortune reported today, January 18, 2011, that Apple’s CEO Steve Jobs went to Basel, Switzerland in 2009 seeking treatment for neuroendocrine cancer. Read the story HERE.…
READ MORESteve Jobs to Take New Medical Leave from Apple
Steve Jobs, CEO and co-founder of Apple and the most well-known member of the carcinoid and neuroendocrine tumor community, is taking a new medical leave of absence. This announcement was reported today, January 17, 2011, by The New York Times, a year…
READ MORE